Abstract
The human splicing factor 2, also called human alternative splicing factor (hASF), is the prototype of the highly conserved SR protein family involved in constitutive and regulated splicing of metazoan mRNA precursors. Here we report that the Drosophila homologue of hASF (dASF) lacks eight repeating arginine-serine dipeptides at its carboxyl-terminal region (RS domain), previously shown to be important for both localization and splicing activity of hASF. While this difference has no effect on dASF localization, it impedes its capacity to shuttle between the nucleus and cytoplasm and abolishes its phosphorylation by SR protein kinase 1 (SRPK1). dASF also has an altered splicing activity. While being competent for the regulation of 5′ alternative splice site choice and activation of specific splicing enhancers, dASF fails to complement S100-cytoplasmic splicing-deficient extracts. Moreover, targeted overexpression of dASF in transgenic flies leads to higher deleterious developmental defects than hASF overexpression, supporting the notion that the distinctive structural features at the RS domain between the two proteins are likely to be functionally relevant in vivo.
ACKNOWLEDGMENTS
We are grateful to R. Bordonné for helpful discussions and for setting up the yeast system in the lab. We thank M. Vervood and the Bloomington Stock Center for fly strains, R. Lührmann for purified U1 snRNP and PIP7 constructs, M. Dorée for purified cdc2 kinase, J. Manley for ASF cDNA and GST-Clk1 expression plasmid, and T. Giannakouros for purified SRPK1. Special thanks go to G. Hildwein for excellent technical assistance. H.-M.B. thanks L. Joulia for his generous help for the transgenic experiments and D. Cribbs for laboratory support.
This work was supported by a grant from the ARC, GEFLUC, and CNRS-INSERM. E.A. was supported by graduate fellowships from the Ministère de l'Education Nationale, de la Recherche et de la Technologie (MENRT), and benefited from a graduate training fellowship from the ARC.